What's in Store for Vertex in 2020 After a Remarkable 2019?

Vertex Pharmaceuticals Incorporated VRTX is well positioned to bring its cystic fibrosis (CF) drugs, Trikafta, Orkambi, Kalydeco and Symdeko, to many more patients while advancing its broad pipeline in additional diseases in 2020.